Trial Profile
The Effect of ACTH (Acthar) on Measures of Chronic Fatigue in Patients With Relapsing Multiple Sclerosis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 22 Jul 2019 Status changed from active, no longer recruiting to completed.
- 31 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 26 Sep 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.